Skip to main content
SpringerLink
Log in

The Role of Drugs in the Treatment of Obesity

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Bandisode, M.S. and Boscheil, B.R.: Double-blind clinical evaluation of mazindol (42-548) in obese diabetics. Current Therapeutic Research 18: 816 (1975).

    PubMed  CAS  Google Scholar 

  • Beckett, A.H.: A comparative study of the pharmacokinetics of fenfluramine, ethylamphetamine, diethylpropion and their metabolites. Current Medical Research and Opinion 6 (Suppl. 1): 107–117 (1979).

    Article  CAS  Google Scholar 

  • Beckett, A.H. and Brookes, L.G.: The metabolism and urinary excretion in man of phentermine, and the influence of N-methyl and p-chloro-substitution. Journal of Pharmacy and Pharmacology 23: 288–294 (1971).

    Article  PubMed  CAS  Google Scholar 

  • Blundell, J.E.; Latham, C.J.; Moniz, E.; McArthur, R.A. and Rogers, P.J.: Structural analysis of the actions of amphetamine and fenfluramine on food intake and feeding behaviour in animals and in man. Current Medical Research and Opinion 6 (Suppl. 1): 34–54 (1979).

    Article  CAS  Google Scholar 

  • Campbell, D.B.: Plasma concentration in fenfluramine and its metabolite, norfenfluramine, following single and repeated oral administration. British Journal of Pharmacology 43: 465 (1971).

    Google Scholar 

  • Carabillo, E.A.: USA drug abuse warning network; in Garattini and Samanin (Eds) Central Mechanism of Anorectic Drugs, pp.461–471 (Raven Press, New York 1978).

    Google Scholar 

  • Clarke, B.F. and Campbell, I.W.: Comparison of metformin and chlorpropamide in non-obese maturity-onset diabetics controlled by diet. British Medical Journal 2: 1576 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Clarke, B.F. and Duncan, L.J.P.: Comparison of chlorpropamide and metformin treatment on weight and blood glucose response of uncontrolled obese diabetics. Lancet 1: 123 (1968).

    Article  PubMed  CAS  Google Scholar 

  • Connell, P.H.: Central nervous system stimulation; in Dukes (Ed) Meyler’s Side Effects of Drugs, Vol. 8, p.l (Excerpta Medica, Amsterdam and Oxford 1975).

  • Craddock, D.: The free diet — 150 cases. International Journal of Obesity 1: 127–134 (1977).

    PubMed  CAS  Google Scholar 

  • Danforth, E.; Burger, A.G.; Goldman, R.F. and Sims, E.A.H.: Thermogenesis during weight gain; in Bray (Ed) Recent Advances in Obesity Research II, p.229 (Newman Publishing Ltd, London 1978).

    Google Scholar 

  • Doar, J.W.H.; Thomson, M.E.; Wilde, C.E. and Sewell, P.F.J.: The influence of fenfluramine on oral glucose tolerance tests, plasma sugar and insulin levels in newly-diagnosed late-onset diabetic patients. Current Medical Research and Opinion 6 (Suppl. 1): 247–254 (1979).

    Article  Google Scholar 

  • Douglas, J.G.; Ford, M.J. and Munro, J.F.: Patient motivation and predicting outcome in a hospital obesity clinic. International Journal of Obesity. (In press, 1981).

  • Duncan, L.J.P.; Rose, K. and Meiklejohn, A.P.: Phenmetrazine hydrochloride and methylcellulose in the treatment of refractory obesity. Lancet 1: 1262 (1960).

    Article  PubMed  CAS  Google Scholar 

  • Editorial: Diethylpropion psychosis. Medical Journal of Australia 2: 1052 (1970).

    Google Scholar 

  • Enzi, G.; Baritussio, A.; Machion, E. and Crepaldi, G.: Short-term and long-term clinical evaluation of a non-amphetamine anorexiant (mazindol) in the treatment of obesity. Journal of International Medical Research 4: 305–318 (1976).

    PubMed  CAS  Google Scholar 

  • Garattini, S.; Borroni, E.; Mennini, T. and Samanin, R.: Differences and similarities among anorectic agents; in Garattini and Samanin (Eds) Central Mechanism of Anorectic Drugs, pp.127–143 (Raven Press, New York 1978).

    Google Scholar 

  • Garrow, J.S.: Weight penalties. British Medical Journal 2: 1171–1172 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Hinsvark, O.N.; Truant, A.P.; Jenden, D.J. and Steinburn, J.A.: The oral bioavailability and pharmacokinetics of soluble and resin-bound forms of amphetamine and phentermine in man. Journal of Pharmacokinetics and Biopharmaceutics 1: 319 (1973).

    CAS  Google Scholar 

  • Hudson, K.D.: The anorectic and hypotensive effect of fenfluramine in obesity. Journal of the Royal College of General Practitioners 27: 497–501 (1977).

    PubMed  CAS  Google Scholar 

  • Innes, J.A.; Watson, M.L.; Ford, M.J.; Munro, J.F.; Stoddart, M.E. and Campbell, D.B.: Plasma fenfluramine levels, weight loss and side effects. British Medical Journal 2: 1322–1325 (1977).

    Article  PubMed  CAS  Google Scholar 

  • Jung, R.T.; Shetty, P.S.; James, W.P.T.; Barrand, M.A. and Callingham, B.: Reduced thermogenesis in obesity. Nature 279: 322–323 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Keen, H.: Antidiabetic agents and vascular events. Journal of Clinical Pathology 28 (Suppl.): 99 (1975).

    Article  Google Scholar 

  • Knatterud, G.L., Meinert, C.L.; Klimt, C.R., Osborne, R.K. and Martin, D.B.: The UGDP: A study of the effects of hypoglycaemic agents on vascular complications in patients with adultonset diabetes. Evaluation of phenformin therapy. Diabetes 24 (Suppl. 1): 65 (1975).

    Google Scholar 

  • Lasagna, L.: Attitude towards appetite suppressants. Journal of the American Medical Association 225: 44 (1973).

    Article  PubMed  CAS  Google Scholar 

  • Lawson, A.A.H.; Strong, J.A.; Roscoe, P. and Gibson, A.: Comparison of fenfluramine and metformin in the treatment of obesity. Lancet 1: 437–441 (1970).

    Article  Google Scholar 

  • Lüllmann-Rauch, R. and Reil, G.H.: Chlorphentermine-induced lipidosis-like ultrastructural changes in lungs and adrenal glands of several species. Toxicology and Applied Pharmacology 30: 408–421 (1974).

    Article  PubMed  Google Scholar 

  • Maclay, W.P. and Wallace, M.G.: A multicenter general practice trial of mazindol in the treatment of obesity. Practitioner 218: 431 (1977).

    PubMed  CAS  Google Scholar 

  • Matthews, P.A.: Diethylpropion in the treatment of obese patients seen in general practice. Current Therapeutic Research 17: 340–346 (1975).

    PubMed  CAS  Google Scholar 

  • Miller, D.S. and Parsonage, S.: Resistance to slimming. Adaption or illusion? Lancet 1: 773 (1975).

    Article  CAS  Google Scholar 

  • Morselli, P.L.; Maggini, C.; Placidi, G.F.; Gemeni, R. and Tegneni, G.: An integrated approach to the clinical pharmacology of anorectic drugs; in Garattini and Samanin (Eds) Central Mechanism of Anorectic Drugs, pp.243–265 (Raven Press, New York 1978).

    Google Scholar 

  • Munro, J.F.; MacCuish, A.C.; Wilson, E.M. and Duncan, L.J.P.: Comparison of continuous and intermittent anorectic therapy in obesity. British Medical Journal 1: 352 (1968).

    Article  PubMed  CAS  Google Scholar 

  • Munro, J.F.; Seaton, D.A. and Duncan, L.J.P.: Treatment of refractory obesity with fenfluramine. British Medical Journal 2: 624–625 (1966).

    Article  PubMed  CAS  Google Scholar 

  • Paeprer, K.: Hypotonie und appetitzugler. Arztol Praxis 22: 1397 (1970).

    Google Scholar 

  • Preston, P.G.; Ford, M.J.; Munro, J.F. and Campbell, D.B.: The variable response to fenfluramine in obesity. International Journal of Obesity 3: 359–361 (1979).

    PubMed  CAS  Google Scholar 

  • Rothwell, N.J. and Stock, M.J.: A role for brown adipose tissue in diet-induced thermogenesis. Nature 281: 31 (1979).

    Article  PubMed  CAS  Google Scholar 

  • Rubin, R.T.: Acute psychotic reaction following ingestion of phentermine. American Journal of Psychiatry 120: 1124 (1964).

    PubMed  CAS  Google Scholar 

  • Rudinger, E. (Ed.): Consumers’ Association: Which way to slim? (Eyre and Spottiswoode, Portsmouth 1978).

    Google Scholar 

  • Sandoz Pharmaceuticals: Sanorex. A monograph (Sandoz Inc, New Jersey 1973).

  • Scoville, B.A.: Review of amphetamine-like drugs by the Food & Drug Administration: Clinical data and value judgements; in Bray (Ed) Obesity in Perspective. Proceedings of the Fogarty Conference, p.441 (US Government, Washington 1973).

    Google Scholar 

  • Seaton, D.A.; Duncan, L.J.P.; Rose, K. and Scott, A.M.: Diethylpropion in the treatment of refractory obesity. British Medical Journal 1: 1009–1011 (1961).

    Article  PubMed  CAS  Google Scholar 

  • Seaton, D.A.; Rose, J. and Duncan, L.J.P.: Sustained-action chlorphentermine in the correction of refractory obesity. Practitioner 193: 698–702 (1964a).

    PubMed  CAS  Google Scholar 

  • Seaton, D.A.; Rose, J. and Duncan, L.J.P.: A comparison of the appetite suppressing properties of dexamphetamine and phentermine. Scottish Medical Journal 9: 482–485 (1964b).

    PubMed  CAS  Google Scholar 

  • Smith, R.C.F.: The long term control of obesity using sustained release appetite suppression. British Journal of Clinical Practice 16: 6–9 (1962).

    Google Scholar 

  • Smith, R.G.; Innes, J.A. and Munro, J.F.: Double-blind evaluation of mazindol in refractory obesity. British Medical Journal 3: 284 (1975).

    Article  PubMed  CAS  Google Scholar 

  • Steel, J.M. and Briggs, W.: Withdrawal depression in obese patients after fenfluramine treatment. British Medical Journal 3: 26–27 (1972).

    Article  PubMed  CAS  Google Scholar 

  • Stunkard, A.J.; Craighead, L.W. and O’Brien, R.: Controlled trial of behaviour therapy, pharmacotherapy and their combination in the treatment of obesity. Lancet 2: 1045–1047 (1980).

    Article  PubMed  CAS  Google Scholar 

  • Turner, P. and Kirby, M.J.: Some evidence for a peripheral mechanism of action of anorectic drugs; in Garattini and Samanin (Eds) Central Mechanism of Anorectic Drugs, pp.295–299 (Raven Press, New York 1978).

    Google Scholar 

  • Waal-Manning, H.J. and Simpson, F.O.: Fenfluramine in obese patients on various antihypertensive drugs. Double-blind controlled trial. Lancet 2: 1392 (1969).

    Article  PubMed  CAS  Google Scholar 

  • Wales, J.K.: The effects of fenfluramine on obese, maturity-onset diabetic patients. Current Medical Research and Opinion 6 (Suppl. 1): 226 (1979).

    Article  Google Scholar 

  • Wallace, A.G.: AN 448 Sandoz (mazindol) in the treatment of obesity. Medical Journal of Australia 1: 343 (1976).

    PubMed  CAS  Google Scholar 

  • Wright, G.J.; Lang, J.F.; Lemieux, R.E. and Goodfriend, M.J.: The objective and timing of drug disposition studies. Appendix III. Diethylpropion and its metabolites in the blood plasma of the human after subcutaneous and oral administration. Drug Metabolism Reviews 4: 267 (1975).

    Article  PubMed  CAS  Google Scholar 

References

  • Bray, G.A.: Obesity in perspective. Proceedings of the Fogarty Conference (US Government, Washington 1973).

  • Craddock, D.: in Obesity and its Management (Churchill Livingstone, London and New York 1973).

    Google Scholar 

  • Garattini, S. and Samanin, R.: in Central Mechanisms of Anorectic Drugs (Raven Press, New York 1978).

    Google Scholar 

  • Garrow, J.S.: in Energy Balance and Obesity in Man, 2nd edition (North Holland Publishing Co, Amsterdam 1978).

  • Munro, J.F.: Clinical aspects of the treatment of obesity by drugs: A review. International Journal of Obesity 3: 171–180(1979).

    PubMed  CAS  Google Scholar 

  • Munro, J.F.: in Treatment of Obesity (MTP Press, Lancaster 1979).

    Google Scholar 

  • Sullivan, A.C. and Cornai, K.: Pharmacological treatment of obesity. International Journal of Obesity 2: 167–190 (1978).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Eastern General Hospital, Edinburgh, Scotland

    J. G. Douglas &  J. F. Munro

  2. Edenhall Hospital, Musselburgh, Midlothian, Scotland

    J. G. Douglas &  J. F. Munro

Authors
  1. J. G. Douglas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. F. Munro
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Douglas, J.G., Munro, J.F. The Role of Drugs in the Treatment of Obesity. Drugs 21, 362–373 (1981). https://doi.org/10.2165/00003495-198121050-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198121050-00004

Keywords

Search

Navigation